Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.

Research paper by Jun J Urushikubo, Shunichi S Yanai, Shotaro S Nakamura, Keisuke K Kawasaki, Risaburo R Akasaka, Kunihiko K Sato, Yosuke Y Toya, Kensuke K Asakura, Takahiro T Gonai, Tamotsu T Sugai, Takayuki T Matsumoto

Indexed on: 23 Oct '18Published on: 23 Oct '18Published in: World journal of gastroenterology


To determine appropriate fecal calprotectin cut-off values for the prediction of endoscopic and histologic remission in Japanese patients with ulcerative colitis (UC). We performed a cross-sectional observational study of 131 Japanese patients with UC and measured fecal calprotectin levels by fluorescence enzyme immunoassay. The clinical activity of UC was assessed with the partial Mayo score (PMS). Relapse was defined as increase of PMS by 2 points or more in stool frequency or rectal bleeding subscore. The endoscopic and histologic activities of UC were evaluated in 50 patients within a 2-mo period from fecal sampling. Endoscopic activity was determined by Mayo endoscopic subscore, Rachmilewitz endoscopic index, and ulcerative colitis endoscopic index of severity. The histologic grade of inflammation was evaluated with biopsy specimens obtained from the endoscopically most severely inflamed site, according to the scheme by Matts grade and Riley's score. Fecal calprotectin levels varied from 1-20783 μg/g. There was a significant correlation between the partial Mayo score and fecal calprotectin levels ( = 0.548, < 0.001). In 50 patients who underwent colonoscopy with biopsy, levels were significantly correlated with the Mayo endoscopic subscore ( = 0.574, < 0.001), Rachmilewitz endoscopic index ( = 0.628, < 0.001), ulcerative colitis endoscopic index of severity ( = 0.613, < 0.001), Riley's histologic score ( = 0.400, = 0.006), and Matts grade ( = 0.586, < 0.001). Receiver-operating characteristic analyses identified the best cut-off value for the prediction of endoscopic remission as 288 μg/g, with an area under the curve of 0.777 or 0.823, while that for histologic remission was 123 or 125 μg/g, with an AUC of 0.881 or 0918, respectively. Of the 131 study patients, 88 patients in clinical remission were followed up 6 mo. During the follow-up period, 19 patients relapsed. The best fecal calprotectin cut-off value for predicting relapse was 175 μg/g. Fecal calprotectin is a predictive biomarker for endoscopic and histologic remission in Japanese patients with UC.

More like this: